The story of Viagra, formerly marketed by copyright, presents a fascinating case study for stakeholders considering the drug landscape . Although its early success and generation of billions in revenue , the intellectual property expiration has opened the floodgates for alternative medications, greatly eroding profit prospects . This shift raises c